Parke-Davis team achieves excellent preclinical results with new EGF receptor TK inhibitor April 13, 1999 No Comments
Karenitecin compound BNP-1350, a promising candidate for treating pediatric cancers April 13, 1999 No Comments
Chemical modification of magainin peptide results in effective, nontoxic antitumor compound April 13, 1999 No Comments
D-24851 --a new tubulin-interacting agent with oral activity and improved therapeutic index April 13, 1999 No Comments
Pierre Fabre features topoisomerase inhibitor in several AACR presentations April 13, 1999 No Comments
News from AACR meeting: NCI evaluating new aminoflavone in preclinical studies April 13, 1999 No Comments
RSS